Executive Series: Aspiring Giants: How Emerging Pharmas Can Grow to $1 Billion—and Beyond
Amid the volatile blend of opportunity and challenge that characterize the global pharmaceutical industry, only a few small companies have managed to catapult their revenue over the $1 billion mark over the past two decades. Whether they chose to expand their therapeutic area focus and product portfolios, enter new geographies, or grow their core business, these aspiring giants pursued three distinct strategies to jump-start growth:
- Leveraging core product / technology capabilities to launch differentiated products
- Using mergers & acquisitions to gain new products and/or expand geographic presence
- Building a strong, stable leadership team armed with a compelling vision and relentless drive
Join us to explore these topics and discuss their applicability to growing the next generation of leading companies, given the rapidly changing healthcare landscape.
|What:||Aspiring Giants: How Emerging Pharmas
Can Grow to $1 Billion—and Beyond
|When:||Tuesday, September 18, 2012
5:30PM – 7:00PM
901 Gateway Blvd.
South San Francisco, CA, 94080
|Attire:||Business attire suggested|
|Attendance:||RSVP by September 17th is required
No on-site registrations accepted
Open to C-Suite Executives of
Life Sciences Companies Only.
|Cost:||BayBio Members – FREE
Non-Members – $75.00